Lantheus Holdings (LNTH) Tops Q1 EPS by 6c, Revenues Beat; Raises FY21 EPS/Revenues Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Lantheus Holdings (LNTH) Announces EXINI Diagnostics AB Receives CE Mark Clearance for aPROMISE in Europe
May 3, 2021 8:35 AM EDTEXINI Diagnostics AB, a subsidiary of Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence (AI) solutions to Find, Fight and Follow serious medical conditions, announced today that it has received CE Mark clearance for aPROMISE in Europe.
aPROMISE is artificial intelligence-based, deep learning-enabled, medical device software that allows healthcare professionals and researchers to perform quantitative assessment of prostate-specific... More
Lantheus (LNTH) Grants AHN Exclusive Rights for Use of Microbubbles in Combination with Ultrasound Assisted Gene Therapy for Development of Proposed Treatment for Xerostomia
April 30, 2021 8:33 AM EDTLantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced a strategic collaboration with Allegheny Health Network (AHN), a western Pennsylvania healthcare delivery system headquartered in Pittsburgh, PA. Under the agreement, Lantheus microbubbles will be used in combination with AHNs ultrasound-assisted non-viral gene transfer (UAGT) technology for the development of a proposed treatment for xerostomia.
Xerostomia, a lack of saliva production leading to dry mouth, has a variety of causes,... More
